吡拉西坦致静脉炎的干预体会  

Intervention experience of phlebitis caused by Laci Staw

作　　者：王维[1] 

机构地区：[1]浙江中医药大学附属第三医院普外科,浙江杭州310005

出　　处：《中国生化药物杂志》2017年第8期176-177,共2页Chinese Journal of Biochemical Pharmaceutics

摘　　要：目的 观察吡拉西坦致静脉炎的因素与护理干预措施,评价其临床效果。方法 以2014年3月-2017年2月为研究时间段,将此期间收治的71例吡拉西坦致静脉炎患者设为研究对象,均给予药物治疗与护理干预,总结临床护理体会。结果 通过对本组患者治疗及护理后10 d后显示,痊愈率为70.49%（43/61）,有效率为29.51%（18/61）,且所有患者均未出现不良反应症状。结论 在给予患者吡拉西坦治疗中应重视静脉炎的发生,密切观察局部反应,做好预防工作,当患者出现此症状后应及时给予硫酸镁、透明贴处理,辅以正确、有效的护理干预,有助于提高临床治疗效果,减少患者痛苦。Objective factors and nursing interventions of phlebitis caused by Laci Staw＆#39;s observation, evaluate its clinical effect. Methods From March 2014 to February 2017 as the study period, 71 cases of piracetam during this period were induced phlebitis were set as the research object, were given drug treatment and nursing intervention, summarize the clinical nursing experience. Results The treatment and nursing of the patients after 10d showed that the cure rate was 70.49% （43/61）, effective rate was 29.51% （18/61）, and all patients had no adverse reaction symptoms. Conclusion In the patients given piracetam treatment should pay attention to the occurrence of phlebitis, close observation of local reaction, to do preventive work, when patients have the symptoms should be promptly given Magnesium Sulfate, transparent paste, proper, effective nursing intervention, help to improve the clinical treatment effect, reduce the suffering of patients.

关 键 词：吡拉西坦 静脉炎 护理干预 

分 类 号：R971[医药卫生—药品]